These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3929594)

  • 41. Esomeprazole magnesium.
    Am J Health Syst Pharm; 2002 Jan; 59(2):127-9. PubMed ID: 11826566
    [No Abstract]   [Full Text] [Related]  

  • 42. Sucralfate--a new drug for duodenal ulcer.
    Med Lett Drugs Ther; 1982 Jan; 24(600):2-3. PubMed ID: 7033749
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparative clinical trial of sucralfate and cimetidine in duodenal ulcer healing.
    Wong CS; Wong NW
    Singapore Med J; 1984 Oct; 25(5):314-5. PubMed ID: 6395347
    [No Abstract]   [Full Text] [Related]  

  • 44. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol.
    Medina Santillán R; Reyes García G; Mateos García E
    Proc West Pharmacol Soc; 1999; 42():33-4. PubMed ID: 10697681
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of gliptide in patients with duodenal ulcers.
    Gilmore AM; McCarthy CF; Feighery C; Weir DG; O'Neill M; Whelton M; Henry RW; Kelly H; Love AH
    Ir Med J; 1977 Dec; 70(20):615-7. PubMed ID: 340416
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of misoprostol and cimetidine on gastric cell labeling index.
    Fich A; Arber N; Sestieri M; Zajicek G; Rachmilewitz D
    Gastroenterology; 1985 Jul; 89(1):57-61. PubMed ID: 3924719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of duodenal ulcer: 400 mg cimetidine twice a day is adequate].
    Panijel M
    Med Klin; 1981 Jul; 76(16):453-5. PubMed ID: 7022151
    [No Abstract]   [Full Text] [Related]  

  • 50. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee. September 15-16, 1988. The ACG Committee on FDA-related matters. American College of Gastroenterology.
    Stern WR
    Am J Gastroenterol; 1989 Apr; 84(4):351-4. PubMed ID: 2494882
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial.
    Hollander D
    J Clin Gastroenterol; 1981; 3(Suppl 2):153-7. PubMed ID: 7033352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
    Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind multicenter comparison of 1,200 mg. and 1,000 mg. cimetidine in hospitalized and ambulatory duodenal ulcer patients.
    Graham DY; Schwartz JT; Sabesin SM; Mann JA; Davis WD; Font RG; Cohen NN
    Am J Gastroenterol; 1981 Dec; 76(6):500-5. PubMed ID: 7036712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M; Dezi A; Ferrario F; Capurso I
    Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer.
    Bianchi Porro G; Petrillo M; De Nicola C; Lazzaroni M
    Scand J Gastroenterol; 1984 Oct; 19(7):905-8. PubMed ID: 6397848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of duodenal ulcer with trental].
    Vorob'ev LP; Ponomarev IuT; Samsonov AA; Agibalov IuV
    Sov Med; 1986; (2):99-102. PubMed ID: 3518079
    [No Abstract]   [Full Text] [Related]  

  • 58. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.